fashion -WSS

fashion

author：knowledge 2025-09-29 20:00:31 - browse：51

Adobe

CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Amazon expands telehealth clinic nationwide

hotspot

WSS

Trump indictment: Who are the 'co

The pink breast cancer awareness ribbon needs a redesign

Scientists inch closer to single

Readout Newsletter: What happened with Sarepta's Duchenne data

The high personal cost of affirmative action for Black doctors

Readout Newsletter: XBI biotech index, Akero Therapeutics

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

hotspot

At least 13 dead in Texas as scorching temps continue

Trump indictment: Who are the 'co

In age of alternative facts, a scholarly course on calling out crap

Diversifying clinical trials isn't enough to close racial gaps: study

DIEP, the 'gold standard' of breast reconstruction, is under threat

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Jerome Adams on the need for new antivirals for Covid

Emergency medicine has repudiated 'excited delirium.' Now what?

Novavax promises a turnaround & Lilly roils the obesity market

The pink breast cancer awareness ribbon needs a redesign

hotspot

Sage hopes for a blockbuster in antidepressant now before FDA

Wildfire pollution widens asthma inequities on Long Island

Physician groups backed by private equity giant lobby on mergers

WHO may add ‘noma' to its list of neglected tropical diseases

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

What the US credit downgrade means for the economy, your finances

knowledge

hotspot

explore

focus